Overview

Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine if treatment with Mucinex D lowers the use of antibiotics in the treatment of upper respiratory infection when compared to placebo
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Reckitt Benckiser Inc.
Reckitt Benckiser LLC
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination
Ephedrine
Guaifenesin
Phenylpropanolamine
Pseudoephedrine
Criteria
Inclusion Criteria:

- patients aged 18 to 75 yrs of age presenting at a clinical site with symptoms
diagnostic for an acute upper respiratory tract infection within the last 5 days

Exclusion Criteria:

- patients who had chronic, recurring respiratory signs and symptoms due to conditions
such as chronic allergic rhinitis, chronic sinusitis or chronic bronchitis which in
the investigator's opinion, confounded interpretation of symptom ratings for the acute
upper respiratory infection. Also excluded were patients with a fever greater than 101
degrees F.